Part 10.1: Life-threatening electrolyte abnormalities

Circulation

Volumn 112, Issue 24 SUPPL., 2005, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CALCIUM CHLORIDE; DIGOXIN; EDETIC ACID; FUROSEMIDE; GLUCONATE CALCIUM; MAGNESIUM SULFATE; PHOSPHATE; POLYSTYRENESULFONATE SODIUM; POTASSIUM; SALBUTAMOL; SORBITOL; THIAZIDE DIURETIC AGENT;

ASYSTOLE; ATAXIA; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; CONFUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DROWSINESS; ECG ABNORMALITY; ELECTROLYTE DISTURBANCE; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPERMAGNESEMIA; HYPERNATREMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; MUSCLE WEAKNESS; PARALYSIS; PRIORITY JOURNAL; SYMPTOMATOLOGY; TORSADE DES POINTES;

EID: 33744824675     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.166563     Document Type: Conference Paper

References (19)

1. Jackson MA, Lodwick R, Hutchinson SG. Hyperkalaemic cardiac arrest successfully treated with peritoneal dialysis. BMJ. 1996;312:1289-1290.
2. Voelckel W, Kroesen G. Unexpected return of cardiac action after termination of cardiopulmonary resuscitation. Resuscitation. 1996;32:27-29.
3. Niemann JT, Cairns CB. Hyperkalemia and ionized hypocalcemia during cardiac arrest and resuscitation: possible culprits for postcountershock arrhythmias? Ann Emerg Med. 1999;34:1-7.
4. Ngugi NN, McLigeyo SO, Kayima JK. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East Afr Med J. 1997;74:503-509.
5. Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis. 1996;28:508-514.
6. Lin JL, Lim PS, Leu ML, Huang CC. Outcomes of severe hyperkalemia in cardiopulmonary resuscitation with concomitant hemodialysis. Intensive Care Med. 1994;20:287-290.
7. Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management [editorial]. J Am Soc Nephrol. 1995;6:1134-1142.
8. Adrogue HJ, Madias NE. Aiding fluid prescription for the dysnatremias. Intensive Care Med. 1997;23:309-316.
9. Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. Am J Med. 1997;102:67-77.
10. Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med. 1997;126:57-62.
11. Gross P, Reimann D, Neidel J, Doke C, Prospert F, Decaux G, Verbalis J, Schrier RW. The treatment of severe hyponatremia. Kidney Int Suppl. 1998;64:S6-S11.
12. Soupart A, Decaux G. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol. 1996;46:149-169.
13. Brunner JE, Redmond JM, Haggar AM, Kruger DF, Elias SB. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol. 1990;27:61-66.
14. Ayus JC, Krothapalli RK, Arieff AI. Treatment of symptomatic hyponatremia and its relation to brain damage: a prospective study. N Engl J Med. 1987;317:1190-1195.
15. Higham PD, Adams PC, Murray A, Campbell RW. Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study. Q J Med. 1993;86:609-617.
16. al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview. Am J Kidney Dis. 1994;24:737-752.
17. Barri YM, Knochel JP. Hypercalcemia and electrolyte disturbances in malignancy. Hematol Oncol Clin North Am. 1996;10:775-790.
18. Aldinger KA, Samaan NA. Hypokalemia with hypercalcemia: prevalence and significance in treatment. Ann Intern Med. 1977;87:571-573.
19. Edelson GW, Kleerekoper M. Hypercalcemic crisis. Med Clin North Am. 1995;79:79-92.